<Record>
<Term>Samarium Sm 153 Lexidronam Pentasodium</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<SemanticType>Organic Chemical</SemanticType>
<ParentTerm>Radioconjugate</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Radiopharmaceutical Compound/Radioconjugate/Samarium Sm 153 Lexidronam Pentasodium</ClassificationPath>
<BroaderTerm>Samarium Sm 153 Lexidronam Pentasodium</BroaderTerm>
<BroaderTerm>Radiopharmaceutical Compound</BroaderTerm>
<BroaderTerm>Radioconjugate</BroaderTerm>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<Synonym>Samarium Sm 153 Lexidronam Pentasodium</Synonym>
<Synonym>Samarium-153 EDTMP</Synonym>
<Synonym>Samarium Sm-153 EDTMP</Synonym>
<Synonym>Sm-153 EDTMP</Synonym>
<Synonym>Sm 153 Lexidronam Pentasodium</Synonym>
<Synonym>Samarium sm 153 lexidronam pentasodium</Synonym>
<Synonym>Samarium-153 Ethylenediaminetetramethylenephosphonate</Synonym>
<Synonym>Quadramet</Synonym>
<Synonym>153Sm-EDTMP</Synonym>
<Synonym>Samarium-153 Ethylenediaminetetramethylenephosphonic Acid</Synonym>
<Synonym>Samarium Sm 153 Lexidronam</Synonym>
<Description>The pentasodium salt of samarium Sm 135 lexidronam, a therapeutic agent consisting of a medium energy beta- and gamma-emitting radioisotope, samarium Sm 135, and a teraphosphonate chelator, ethylenediaminetetramethylene phosphonic acid (EDTMP). The chelator moiety of samarium Sm 153 lexidronam associates with hydroxyapatite crystals concentrated in areas of bone turnover, thereby selectively delivering samarium Sm 153-mediated cytotoxic radiation to osteoblastic bone metastases.</Description>
<Source>FDA Registry</Source>
<Source>NCI Thesaurus</Source>
</Record>
